Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.
Biglia
N
N
Gynaecological Oncology Department, University of Turin, Italy. nbiglia@mauriziano.it
Mariani
L
L
Ponzone
R
R
Sismondi
P
P
D001943:Breast Neoplasms / Q000235:genetics* / Q000517:prevention & control*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D005187:Fallopian Tubes / Q000601:surgery; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics / Q000517:prevention & control; D010052:Ovariectomy
D003278:Contraceptives, Oral, Hormonal